Pfizer, Allergan CEOs: Tie-up aims to produce more meds, sales, isn't focused on cutting costs

Pfizer, Allergan CEOs: Tie-up aims to produce more meds, sales, isn't focused on cutting costs


The heads of drugmakers Pfizer and Allergan said Tuesday that the record $160 billion combination they're planning is meant to produce more medicines and boost revenue, not to just slash jobs and other costs as the companies previously have done. The deal announced last November would move Pfizer's official headquarters for tax purposes from New York to Allergan's base in Ireland.



from Biotech News